Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Effect of renal impairment on atherosclerosis: only partially mediated by homocysteine.

Spence JD, Urquhart BL, Bang H.

Nephrol Dial Transplant. 2016 Jun;31(6):937-44. doi: 10.1093/ndt/gfv380. Epub 2015 Nov 14.

PMID:
26567910
2.

Cystathionine β-synthase inhibition is a potential therapeutic approach to treatment of ischemic injury.

Chan SJ, Chai C, Lim TW, Yamamoto M, Lo EH, Lai MK, Wong PT.

ASN Neuro. 2015 Apr 13;7(2). pii: 1759091415578711. doi: 10.1177/1759091415578711. Print 2015 Mar-Apr.

3.

Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals.

Clarke R, Bennett D, Parish S, Lewington S, Skeaff M, Eussen SJ, Lewerin C, Stott DJ, Armitage J, Hankey GJ, Lonn E, Spence JD, Galan P, de Groot LC, Halsey J, Dangour AD, Collins R, Grodstein F; B-Vitamin Treatment Trialists’ Collaboration.

Am J Clin Nutr. 2014 Aug;100(2):657-66. doi: 10.3945/ajcn.113.076349. Epub 2014 Jun 25.

4.

Intensive risk factor control in stroke prevention.

Spence JD.

F1000Prime Rep. 2013 Oct 1;5:42. doi: 10.12703/P5-42. Review.

5.

Homocysteine and C-reactive protein associated with progression and prognosis of intracranial branch atheromatous disease.

Men X, Li J, Zhang B, Zhang L, Li H, Lu Z.

PLoS One. 2013 Sep 11;8(9):e73030. doi: 10.1371/journal.pone.0073030. eCollection 2013.

6.

B Vitamins and Antioxidants Intake is Negatively Correlated with Risk of Stroke in Iran.

Hariri M, Maghsoudi Z, Darvishi L, Askari G, Hajishafiee M, Ghasemi S, Khorvash F, Iraj B, Ghiasvand R.

Int J Prev Med. 2013 May;4(Suppl 2):S284-9.

7.

Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging.

Wardlaw JM, Smith C, Dichgans M.

Lancet Neurol. 2013 May;12(5):483-97. doi: 10.1016/S1474-4422(13)70060-7. Review. Erratum in: Lancet Neurol. 2013 Jun;12(6):532.

8.

Vitamin B12 in health and disease.

O'Leary F, Samman S.

Nutrients. 2010 Mar;2(3):299-316. doi: 10.3390/nu2030299. Epub 2010 Mar 5. Review.

9.

Effect of folic acid supplementation on cardiovascular outcomes: a systematic review and meta-analysis.

Zhou YH, Tang JY, Wu MJ, Lu J, Wei X, Qin YY, Wang C, Xu JF, He J.

PLoS One. 2011;6(9):e25142. doi: 10.1371/journal.pone.0025142. Epub 2011 Sep 28. Review.

10.

Homocysteine lowering interventions for preventing cardiovascular events.

Martí-Carvajal AJ, Solà I, Lathyris D, Salanti G.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006612. doi: 10.1002/14651858.CD006612.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;1:CD006612.

11.

ACE D/I polymorphism, migraine, and cardiovascular disease in women.

Schürks M, Zee RY, Buring JE, Kurth T.

Neurology. 2009 Feb 17;72(7):650-6. doi: 10.1212/01.wnl.0000342517.97178.f6.

12.

Risk factor management to prevent first stroke.

Rundek T, Sacco RL.

Neurol Clin. 2008 Nov;26(4):1007-45, ix. doi: 10.1016/j.ncl.2008.09.001. Review.

13.

Invited commentary: Preventing neural tube defects and more via food fortification?

Mills JL, Carter TC.

Am J Epidemiol. 2009 Jan 1;169(1):18-21; discussion 22-3. doi: 10.1093/aje/kwn329. Epub 2008 Oct 25.

14.

Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease.

Schürks M, Zee RY, Buring JE, Kurth T.

Neurology. 2008 Aug 12;71(7):505-13. doi: 10.1212/01.wnl.0000316198.34558.e5. Epub 2008 Jul 30.

15.

Factors associated with the steep increase in late-midlife stroke occurrence among US men.

Towfighi A, Saver JL, Engelhardt R, Ovbiagele B.

J Stroke Cerebrovasc Dis. 2008 Jul-Aug;17(4):165-8. doi: 10.1016/j.jstrokecerebrovasdis.2007.12.007.

16.

Homocysteine and cardiovascular disease: should we treat?

Potter K.

Clin Biochem Rev. 2008 Feb;29(1):27-30. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk